Compare Cronos Group Inc (CRON) vs JPMorgan Equity Premium Income ETF (JEPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cronos Group Inc vs JPMorgan Equity Premium Income ETF — how do they compare? Cronos Group Inc trades at $3.23 (market cap $1.18B), while JPMorgan Equity Premium Income ETF trades at $56.77 (market cap $45.55B). The key difference: JPMorgan Equity Premium Income ETF is far larger — about 38.6× Cronos Group Inc's market cap, and Cronos Group Inc is trading nearer its 52-week high, JPMorgan Equity Premium Income ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Cronos Group Inc for 22 Days and JPMorgan Equity Premium Income ETF for 57 Days on average.
| CRON | JEPI | |
|---|---|---|
Market Cap | $1.18B | $45.55B |
Volume | 968,037 | 3,820,809 |
Sector | Health | Income / Options Overlay |
52-Week High | $3.55 | $59.88 |
52-Week Low | $2.30 | $55.29 |
Typical Hold Time | 22 Days | 57 Days |
Enterprise Value | $387.62M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.22, down 0.62% on the day, amid a bearish technical signal. The stock shows mixed earnings history, with recent beats in Q1 and Q2 2026 but a miss in Q4 2025. Revenue growth is robust, increasing from $118M in 2024 to $147M in 2025, with a projected rise to $179M in 2026. However, profitability remains volatile, with a net loss of $9.45M in 2025 despite a strong gross margin of 45.86%. Recent news highlights the company's Investor Day focusing on global expansion and cash flow generation.
The outlook for CRON is cautiously optimistic, driven by international growth and a debt-free balance sheet with $827M in cash. Key risks include ongoing profitability challenges, competitive pressures, and regulatory uncertainties in the cannabis sector. Analyst sentiment is mixed, with 60% hold ratings, suggesting a wait-and-see approach. Investors should weigh strong revenue trends against execution risks and margin volatility.
JEPI trades at $56.67, up 0.39% with a bearish technical signal from moving averages while oscillators remain neutral. The ETF shows consistent dividend distributions with recent payments of $0.37 per share. Recent media coverage focuses on JEPI's role in income strategies and tax implications of dividend reinvestment.
The covered-call strategy provides income but may limit upside during rallies. Current sentiment is mixed with institutional interest growing but technical indicators suggesting caution. Key risks include interest rate sensitivity and the trade-off between income generation and capital appreciation potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →About JPMorgan Equity Premium Income ETF
JEPI is an actively managed ETF that seeks to deliver monthly income and stock market exposure with lower volatility. It combines an equity portfolio with an options strategy to generate steady premiums.
Read more on JEPI →
